AMA, Scripps, JAX launch education series on precision medicine

The American Medical Association (AMA), in partnership with Scripps Translational Science Institute (Scripps) and The Jackson Laboratory (JAX), today announced a new online program aimed at educating physicians and other health care professionals on the benefits and limitations of genetic testing and when it is appropriate to incorporate it into their practices.

As part of the new 12-module "Precision Medicine for Your Practice" series, the organizations today launched the first educational module focused on expanded carrier screening. The module will help physicians who provide prenatal care to understand the benefits and limitations of using expanded genetic screening panels to estimate whether expectant and prospective parents risk passing on to their children dozens of conditions. The 11 future modules will focus on other applications of genetic testing, including targeted therapy in oncology, genomic sequencing, cardiogenomics, neurogenomics, pharmacogenomics and ethics in precision medicine.